Prevention of cancers of the breast, endometrium and ovary. - Wikidata - wikimedia - TriplyDB

Prevention of cancers of the breast, endometrium and ovary.

Prevention of cancers of the breast, endometrium and ovary.

http://www.wikidata.org/entity/Q35868030

about

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Municipal distribution of ovarian cancer mortality in Spain.High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma Time trends in municipal distribution patterns of cancer mortality in Spain.Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.Counting human somatic cell replications: methylation mirrors endometrial stem cell divisions.Diabetic oncopathy--one more yet another deadly diabetic complication!Is oestrogen an important player in melanoma progression?Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer.Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: what is in common?15. Cancers attributable to reproductive factors in the UK in 2010.Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.The role of obesity in cancer survival and recurrence.Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER In situ breast cancer and microchimerism.Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study.Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort.BRCA and Early Events in the Development of Serous Ovarian Cancer.The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer.Epigenetics of endometriosis.Time since first sexual intercourse and the risk of cervical cancer.Breast cancer prevention based on gene-environment interaction.Does mammographic density reflect the expression of breast cancer markers?Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.Insulin-like growth factor-I regulates GPER expression and function in cancer cells.Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells.G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan.Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats.Effect of Genistein and 17-β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line.Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis.Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan.Variability of reproductive history across the Swiss SAPALDIA cohort--patterns and main determinants.A case-control study of breast cancer risk factors in 7,663 women in Malaysia

P2860

Q24810733-28C2E3E5-D789-4288-A5C2-2856BBB915B7 Q33369216-D303ED07-0F78-4AC5-9517-B5A88DC7C7A2 Q33898496-277FFC3C-4043-41F8-A6F4-F58B56FC92CE Q34012094-EF65259D-2CD1-4C01-98DF-EA107FC61C12 Q34044998-BCC7D977-B47F-4459-AFA5-0292CDA618B3 Q34201766-FD384987-6CD2-4880-9931-558D1BB93658 Q34272097-7E2EF8FC-2B65-4B14-9C7D-8F7E7467DA07 Q34589095-CC856738-EC94-45D6-88D4-FE1987060929 Q34610260-5ECFB230-0778-4F19-A0A4-8E3EF1F00A8F Q35074718-F6755FC8-8E75-4DAE-8FFD-F7BF70DF06D7 Q35234621-B1241DE4-F222-480A-917A-9E5F0DDA040D Q35654685-F59356B9-8A63-49F7-9E35-46A7CBB2F726 Q35851839-60F4C8A8-DBCA-4A72-B41A-C5A34F3A0E0F Q36152955-8269264D-C9BD-47FF-B510-D04A538E454C Q36368070-CE5779EB-A1CD-4086-89E1-8B3C526408E3 Q36447526-B780ABCF-20AB-4946-AF9C-2CB81EEA8EB6 Q36800401-2B4D09E9-3BAE-45E9-91C4-E40D451394B6 Q37005148-7CAF4504-A54B-4045-B13A-995C1CC8D0DD Q37041520-1ED433DF-FC37-43B3-B9BD-D763F819B044 Q37480768-8C58089C-05E7-48DB-BB43-D08152367655 Q37513137-BED816E2-6E75-4FE6-B97E-CB275BFCCF84 Q37522285-CC553420-DDBF-4445-AF9B-60536AA6A3BF Q37571067-185BD174-F970-4898-B0AF-D2D69C3221E6 Q37695585-F4799247-EE57-4707-BF98-145196EAC7F0 Q37861636-5653BF54-F92B-477D-A17C-C64BD7769B6E Q38101685-7ADEEE19-C819-4C5A-B70F-E2C378507BEA Q39023460-D762BA28-F3E9-4852-9404-C51B3BEED44C Q39376878-052455AB-C3EE-48C5-8DC9-35167A775F06 Q39481964-690EB3F9-8E6A-47BC-99C7-4ACA718E31AF Q39800227-0470BC5B-A433-4359-8C3A-E85640F6EDC9 Q41235381-677DD692-05A1-4D12-AC0B-9D9C65A2B9FC Q42363729-2E201682-16CD-4492-8DCF-9D60E0D63351 Q43908941-0CA02ADF-4F4B-42EA-B248-75D5445B7D9C Q46359847-66DE6AFD-911D-4A93-861D-ADBABA634B4D Q49189762-FE9764B1-D8C4-48B9-BA31-A198256E6DFA Q50518666-6B7A4ED5-D07A-44C6-A0D3-F76646D03CCC Q51414790-C534321F-597E-4FF2-BD56-0414C29A7374 Q51746956-09ABC64D-A352-4572-83B6-9DC3C2C5035E Q58741224-25857DEA-E259-42B7-99DC-5FC1A091E936

P2860

Prevention of cancers of the breast, endometrium and ovary.

http://www.wikidata.org/entity/Q35868030

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Prevention of cancers of the breast, endometrium and ovary.

@ast

Prevention of cancers of the breast, endometrium and ovary.

@en

type

label

Prevention of cancers of the breast, endometrium and ovary.

@ast

Prevention of cancers of the breast, endometrium and ovary.

@en

prefLabel

Prevention of cancers of the breast, endometrium and ovary.

@ast

Prevention of cancers of the breast, endometrium and ovary.

@en

P1433

Q35868030-57F0D473-80F3-4AA7-9311-748C0A65BCC2

P1476

Q35868030-214DE0FB-B6B0-4436-94E5-3AA8743AF0F4

P2093

Q35868030-29411E48-B7C9-431A-BB83-8750A8B3169B

Q35868030-C275ECB2-AE08-49FB-AA2E-F53AB2CC7BB4

Q35868030-CE89A488-EBB9-4750-B7E3-FC8317D8E224

P2860

Q35868030-0D91CBA0-7095-4E93-82E6-32F8A20878E0

Q35868030-0FDBB11C-EB79-410B-A47E-C401E1DC7903

Q35868030-147202C0-B2EF-4442-AC3B-2EDF42C568B9

Q35868030-160D588C-87D5-40B3-8A06-708965226D05

Q35868030-1EA13E13-419D-42E2-AE5B-6CDE02DA4619

Q35868030-2165C9FA-6FB2-4889-B7A4-AB77F5DCA2BE

Q35868030-25268CBE-0872-4A5E-9941-E40FA0404FB9

Q35868030-28E1F654-7BA0-4197-9512-E4DADA144B3B

Q35868030-2A9366A5-0320-4B57-9A29-F8CFBF22AE5D

Q35868030-2D0365DB-9236-4E06-937C-91FA53656229

P2888

Q35868030-C500DEC5-620D-470D-90E1-F9C608D6C91F

P304

Q35868030-C185AA62-C535-4377-91C7-63C101FF3814

P31

Q35868030-8ADE5091-3FF8-41D2-9F21-B01CCBC8FCF1

P356

Q35868030-A8FE4120-8A2C-4CF4-B9C6-2B5390E6045C

P407

Q35868030-52FE4304-159D-4E7C-85DF-E845B61CE2B6

P433

Q35868030-F6A497A1-C9B5-462E-8D31-BABDBD0FD8D0

P478

Q35868030-D18E678D-D9F7-4F57-9B91-5D69A0E51DDB

P577

Q35868030-E28AFA37-CA4E-458A-BEBA-3D2FB5F9222A

P5875

Q35868030-841729D6-4F70-411A-A48C-B9B9C81F626C

P698

Q35868030-EB6DAFB6-5585-48A8-B52E-147098FB7E3D

P356

P1433

P1476

Prevention of cancers of the breast, endometrium and ovary.

@en

P2093

Anna H Wu

http://www.w3.org/2001/XMLSchema#string

Celeste Leigh Pearce

http://www.w3.org/2001/XMLSchema#string

Malcolm C Pike

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

Intratumoral levels of estrogens in breast cancer.

Tamoxifen prevention of breast cancer: an instance of the fingerpost.

The action of chorionic gonadotrophin in the obese.

Somatic stem cells and the kinetics of mutagenesis and carcinogenesis.

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

P2888

P304

6379-6391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1207899

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8388550

http://www.w3.org/2001/XMLSchema#string

P698

15322512

http://www.w3.org/2001/XMLSchema#string